Sigyn Therapeutics

Making Cancer Therapy More Effective

About this Event

Sigyn Therapeutics (OTCQB: SIGY) is creating therapeutic solutions that overcome current limitations in healthcare.

One of the reasons cancer therapies like checkpoint inhibitors and chemotherapy have such a low success rate is that tumor derived exosomes and drug decoys can prevent therapeutics from reaching their targets. Sigyn’s ImmunePrep platform enhances the activity of antibody-based immunotherapies while ChemoPrep improves the delivery of cancer chemotherapies, and ChemoPure reduces the post-treatment toxicity of chemotherapy.

In addition, Sigyn is developing a modular feasibility study for Sigyn Therapy to help extend the lives of end-stage renal disease patients.

Watch our webinar with Sigyn co-founder and CEO, Jim Joyce, to hear how Sigyn’s patented devices improve the performance of drugs that treat cancer.

Hosted by FORCE Family Office CEO, Steven Saltzstein

Video On Demand

– Recorded

August 22

SHARE THIS EVENT

All statements and expressions are the sole opinion of the company and are subject to change without notice. The Company is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial advisor, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. Information contained herein contains “forward looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities and Exchange Act of 1934, as amended. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be “forward looking statements”. Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of words such as “expects”, “will”, “anticipates”, “estimates”, “believes”, or by statements indicating certain actions “may”, “could”, “should” or “might” occur.